KRAS and neoplasm: Results indicated cytotoxic CD8+ T‐cell tumor infiltrate was unlikely to correlate with KRAS mutation type by demonstrating comparable tumor‐infiltrating cytotoxic CD8+ T‐cell density in CRC tissues with different types of KRAS mutations (Figure 1D).